Willis Investment Counsel

Position in LLY — ELI LILLY & Co

CIK 1310929 GAINESVILLE, GA

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$21,610,132

+$8,018,691 QoQ

Shares Held

18,017

+21.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.06%

of 13F equity value

Holder Rank

#857

of 4,621 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Willis Investment Counsel holds $210,142,319 across 6 Drug Manufacturers - General names. LLY ranks #5 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	309,486	$78,600,159
2	PFE	Pfizer Inc	1,818,508	$43,789,672
3	MRK	Merck & Co., Inc.	312,767	$40,190,559
4	SNY	Sanofi	602,300	$25,694,118
5	LLY	ELI LILLY & Co This page	18,017	$21,610,132
6	ABBV	AbbVie Inc.	1,024	$257,679

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,610,132	18,017	+21.9%	Shares	Sole	2026-08-03
2026-03-31	$13,591,441	14,777	-29.4%	Shares	Sole	2026-05-05
2025-12-31	$22,488,755	20,926	+5.8%	Shares	Sole	2026-01-22
2025-09-30	$15,084,510	19,770	+109.1%	Shares	Sole	2025-11-05
2025-06-30	$7,371,235	9,456	+3.7%	Shares	Sole	2025-08-12
2022-09-30	$2,947,658	9,116	-10.8%	Shares	Sole	2022-10-12
2022-06-30	$3,312,333	10,216	-79.6%	Shares	Sole	2022-08-08
2022-03-31	$14,323,081	50,016	-2.3%	Shares	Sole	2022-05-16
2021-12-31	$14,141,635	51,197	-1.6%	Shares	Sole	2022-02-14
2021-09-30	$12,017,141	52,011	-54.4%	Shares	Sole	2021-11-17
2021-06-30	$26,190,756	114,111	-20.7%	Shares	Sole	2021-08-13
2021-03-31	$26,885,453	143,911	-10.1%	Shares	Sole	2021-05-17
2020-12-31	$27,016,257	160,011	+1189.3%	Shares	Sole	2021-02-11
2020-06-30	$2,037,637	12,411	-0.2%	Shares	Sole	2020-08-14
2020-03-31	$1,724,428	12,431	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.